Literature DB >> 16246862

GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.

Lawrence Engmann, Claudio Benadiva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16246862     DOI： 10.1093/humrep/dei190

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  4 in total

1.  Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome.

Authors:  Kathleen E O'Neill; Suneeta Senapati; Anuja Dokras
Journal:  Fertil Steril       Date:  2014-11-06       Impact factor: 7.329

2.  Different gonadotropin releasing hormone agonist doses for the final oocyte maturation in high-responder patients undergoing in vitro fertilization/intra-cytoplasmic sperm injection.

Authors:  Emre Goksan Pabuccu; Recai Pabuccu; Gamze Sinem Caglar; Banu Yılmaz; Aslı Yarcı
Journal:  J Hum Reprod Sci       Date:  2015 Jan-Mar

3.  Evaluation of uterine receptivity after gonadotropin releasing hormone agonist administration as an oocyte maturation trigger: a rodent model.

Authors:  Kenji Ezoe; Nana Murata; Akiko Yabuuchi; Tamotsu Kobayashi; Keiichi Kato
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

4.  Comparison of Triggering Final Oocyte Maturation with Follicle Stimulating Hormone Plus Human Chorionic Gonadotropin, versus Human Chorionic Gonadotropin Alonein Normoresponder Women Undergoing Intracytoplasmic Sperm Injection: A Randomized Clinical Trial.

Authors:  Soheila Ansaripour; Nayereh Tamizi; Mohammad Reza Sadeghi; Azam Mohammad-Akbari
Journal:  Int J Fertil Steril       Date:  2022-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.